Fungal infections, caused by various fungi, can affect different parts of the body and present a spectrum of illnesses ranging from mild to severe. Common types include superficial infections like ringworm and athlete's foot, as well as more serious systemic infections that can impact internal organs. Risk factors for fungal infections include weakened immune systems, certain medical treatments, and environmental exposures. Candida species are common culprits, causing infections such as thrush and vaginal yeast infections. Aspergillus and Cryptococcus can lead to serious respiratory infections, particularly in immunocompromised individuals. Diagnosis involves clinical assessment and laboratory testing, with treatment varying based on the type and severity of the infection. Antifungal medications, both topical and systemic, are commonly prescribed. However, resistance to antifungal drugs is a growing concern. Preventive measures include maintaining good hygiene, avoiding prolonged exposure to damp environments, and addressing underlying health conditions. Fungal infections highlight the importance of both proper diagnosis and timely, targeted treatment to ensure favorable outcomes. Ongoing research aims to improve diagnostic methods, treatment options, and our understanding of the complex interactions between fungi and the human immune system.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey